Stress Testing HCA: Historical Drawdowns and Macro Risks
This article analyzes HCA Healthcare's (HCA) stock performance during 12 major market crises, revealing an average drawdown of -20% compared to the S&P 500's -13%. It details HCA's response to events like the COVID-19 crash, US debt ceiling crisis, and inflation shock, showing significant stock declines. The article advises investors to recognize this predictable behavior as a mathematical feature and utilize a rule-based, diversified approach to ride out market resets.
HCA Healthcare, Inc. $HCA Shares Sold by Rathbones Group PLC
Rathbones Group PLC decreased its stake in HCA Healthcare (NYSE:HCA) by 12.2% in the fourth quarter, selling 5,532 shares and retaining 39,771 shares valued at $18.6 million. Despite HCA reporting mixed first-quarter earnings with a slight revenue beat but an EPS miss, Wall Street analysts maintain a "Moderate Buy" rating for the company. HCA Healthcare also announced a quarterly dividend of $0.78 per share, reflecting confidence from the company.
HCA Healthcare, Inc. $HCA Holdings Cut by Diamond Hill Capital Management Inc.
Diamond Hill Capital Management Inc. significantly reduced its stake in HCA Healthcare by 92.9% in the fourth quarter, selling 618,170 shares. Despite this large sale, institutional ownership remains high at 62.73%, with other funds increasing their positions. Analysts generally maintain a "Moderate Buy" rating for HCA Healthcare with an average target price of $515.77, though some have adjusted their targets downwards.
HCA Healthcare Stock Plummets -9.3% With 5-Day Losing Streak
HCA Healthcare stock has experienced a significant downturn, plummeting 9.3% over a five-day losing streak, resulting in a $9.0 billion reduction in its market cap. Despite a low valuation, the stock is considered risky due to weak operating performance and financial condition. The article suggests focusing on predictive signals for risk management rather than post-event notifications.
HCA Healthcare Stock Plummets -9.3% With 5-Day Losing Streak
HCA Healthcare (HCA) has experienced a significant 5-day losing streak, with its stock plummeting 9.3% and its market cap falling by $9.0 billion to $88 billion. Despite a low valuation, the company's weak operating performance and financial condition make the stock appear risky. The article suggests that such market moves are already priced in, emphasizing the need for predictive signals over notifications for managing individual stock risk.
Stroke warning signs: HCA Healthcare stroke survivors share why it’s important to B.E. F.A.S.T.
During Stroke Awareness Month, HCA Healthcare emphasizes the critical importance of recognizing stroke symptoms early by using the B.E. F.A.S.T. acronym. HCA Healthcare has significantly reduced door-to-needle times for stroke treatment and partners with the American Heart Association to improve prevention and care. The article shares inspiring stories of several stroke survivors, including an ER nurse, a collegiate athlete, a father, a doctoral student, and a CNA student, all of whom benefited from quick action and highlight the diverse circumstances in which strokes can occur.
Ameresco director Wisneski sells $302,900 in AMRC stock
Ameresco director Francis V. Wisneski Jr. sold 10,000 shares of AMRC stock for $302,900 on May 19, 2026, while also acquiring 10,000 shares through a stock option exercise. This transaction follows recent developments for Ameresco, including a joint venture with HA Sustainable Infrastructure Capital Inc. and varying price target adjustments from analysts.
HCA Healthcare Stock Outlook: Is Wall Street Bullish or Bearish?
HCA Healthcare (HCA) has underperformed the broader market and healthcare sector ETFs, with its stock up only 3.3% over the past year compared to the S&P 500's 26.7% gain, and down 15.5% YTD. This underperformance follows weaker-than-expected Q1 2026 adjusted EBITDA results due to reduced patient volumes. Despite this, analysts maintain a "Moderate Buy" consensus rating with a mean price target suggesting a 30.1% upside.
HCA Healthcare Inc. stock outperforms competitors despite losses on the day
HCA Healthcare Inc. (HCA) dropped 1.04% to $392.56, marking its fifth consecutive day of losses. Despite this, the stock outperformed general market indices like the S&P 500 Index (SPX) and the Dow Jones Industrial Average (DJIA), which both saw gains. The article notes the stock's performance on what was otherwise a positive trading session for the broader market.
HCA: EBITDA headwinds from APTC expiration are manageable; growth and innovation initiatives remain on track
HCA Management indicates that the $600M–$900M EBITDA headwind from APTC expiration is manageable, with Q1 performing at the lower end of this range. The company is on track with operational improvements, a $400M resiliency program, and strategic capital deployment focused on outpatient growth and DT&I investments. Policy changes are also considered manageable.
HCA Healthcare Inc. stock underperforms Wednesday when compared to competitors
HCA Healthcare Inc. (HCA) stock fell by 1.98% to $396.67 on Wednesday, underperforming the broader market which saw the S&P 500 Index rise by 1.08% and the Dow Jones Industrial Average climb by 1.31%. This marked the fourth consecutive day of losses for HCA Healthcare.
Nutex Health or HCA Healthcare: Which Stock Has More Upside?
This article compares Nutex Health (NUTX) and HCA Healthcare (HCA) stocks, concluding that NUTX offers more upside due to superior revenue growth, better profitability, and lower valuation. While HCA's stock previously fell, NUTX demonstrates stronger fundamentals in recent periods. The analysis includes detailed financial comparisons on growth, margins, momentum, and valuation multiples.
HCA Healthcare, Inc. $HCA Shares Sold by Resona Asset Management Co. Ltd.
Resona Asset Management Co. Ltd. reduced its stake in HCA Healthcare by 9.6% in the fourth quarter, selling 5,691 shares and retaining 53,323 shares valued at approximately $24.96 million. This comes as HCA Healthcare reported Q1 earnings of $7.15 per share, slightly below estimates, though revenue of $19.11 billion exceeded expectations with a 4.3% year-over-year increase. The company also declared a quarterly dividend of $0.78 per share, and analysts maintain a "Moderate Buy" consensus with an average price target of $515.77.
5,006 Shares in ResMed Inc. $RMD Acquired by North Dakota State Investment Board
The North Dakota State Investment Board recently acquired 5,006 shares of ResMed Inc. (NYSE:RMD), valued at approximately $1.2 million, during the fourth quarter. This acquisition comes as ResMed reported strong quarterly results, exceeding analyst expectations for both EPS and revenue, and announced a quarterly dividend of $0.60 per share. Several other institutional investors have also adjusted their holdings in ResMed, while analysts maintain a "Moderate Buy" consensus rating for the stock despite recent insider selling.
Fideuram Intesa Sanpaolo Private Banking S.P.A. Invests $5.50 Million in HCA Healthcare, Inc. $HCA
Fideuram Intesa Sanpaolo Private Banking S.P.A. recently invested $5.50 million in HCA Healthcare, Inc., acquiring 11,777 shares in the fourth quarter. This move highlights continued institutional interest in HCA, with hedge funds and institutions holding a significant portion of the company's stock. Despite recent price target adjustments by analysts, HCA Healthcare maintains a "Moderate Buy" consensus rating with an average target price of $515.77.
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors
HCA Healthcare Inc. (HCA) stock fell by 4.28% on Tuesday, closing at $404.69, significantly underperforming its competitors. The decline occurred during a negative trading session for the broader market, with both the S&P 500 Index and Dow Jones Industrial Average also seeing decreases. This marks the third consecutive day of losses for HCA Healthcare.
Inside HCA staffers' 350,000 volunteer hours helping nonprofits
HCA Healthcare announced the results of its seventh annual "We Show Up for Our Communities" volunteer initiative. Colleagues across the country volunteered over 41,800 hours to support 1,866 nonprofits through initiatives like packing snack bags for students. In 2025, HCA Healthcare colleagues accumulated over 350,000 volunteer hours and supported over 10,000 charitable organizations nationwide.
HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative
HCA Healthcare announced that its colleagues volunteered over 41,800 hours during its seventh annual "We Show Up for Our Communities" initiative, supporting 1,866 nonprofits nationwide. This effort involved 9,790 volunteers, with significant participation in Nashville where nearly 3,000 colleagues contributed almost 13,500 hours. The company also highlighted its broader commitment, with over 350,000 volunteer hours and $8.3 million in grants awarded in 2025.
HCA Healthcare, Inc. $HCA Shares Sold by Maj Invest Holding A S
Maj Invest Holding A S significantly reduced its stake in HCA Healthcare by 48.4% in the fourth quarter, selling 163,916 shares and retaining 174,594 shares valued at $81.5 million. HCA Healthcare reported mixed Q4 results, with EPS slightly missing estimates at $7.15 but revenue exceeding expectations at $19.11 billion, a 4.3% year-over-year increase. The company also declared a quarterly dividend of $0.78 per share, which annualizes to a 0.7% yield.
JPMorgan Adjusts Price Target on HCA Healthcare to $490 From $535, Maintains Neutral Rating
JPMorgan has revised its price target for HCA Healthcare (HCA) to $490, down from the previous $535, while keeping a Neutral rating on the stock. This adjustment reflects a moderated outlook for the healthcare provider's valuation.
JPMorgan Adjusts Price Target on HCA Healthcare to $490 From $535, Maintains Neutral Rating
JPMorgan has revised its price target for HCA Healthcare (NYSE: HCA) to $490, down from the previous $535, while keeping a "Neutral" rating on the stock. This adjustment reflects a moderated outlook for the healthcare provider. The article also mentions other recent analyst target adjustments for HCA Healthcare from firms like Argus, Deutsche Bank, Bernstein, Oppenheimer, and Truist, indicating a general trend of re-evaluating the company's valuation.
Handelsbanken Fonder AB Boosts Position in HCA Healthcare, Inc. $HCA
Handelsbanken Fonder AB increased its stake in HCA Healthcare, Inc. by 7.9% in the fourth quarter, bringing its total holdings to 213,272 shares valued at approximately $99.6 million. Institutional investors collectively own 62.73% of HCA's stock. Despite missing consensus EPS estimates slightly, HCA Healthcare reported a revenue beat and provided optimistic FY2026 EPS guidance, while analysts maintain a "Moderate Buy" rating with an average target price of $517.82.
The 'corporate takeover' of physician practices accelerates: study
A new report by Avalere Health for the Physicians Advocacy Institute reveals a significant acceleration in the corporate acquisition of physician practices, with over four in five U.S. physicians employed by hospitals, health systems, or corporate entities by the end of 2025. This trend, termed a "corporate takeover," has reduced the number of physicians in physician-owned settings to just 18% and is impacting clinical autonomy and patient care. While consolidation offers some physicians better work-life balance and higher pay, it raises concerns about corporate interference in medical decision-making and the long-term viability of independent practices.
CVS Earnings Story Gains Fresh S&P 500 Attention
The latest CVS Health earnings discussion has brought renewed attention to its healthcare operations within the S&P 500. The discussion highlighted unusual expenses and operational resilience, prompting questions about earnings quality and long-term stability. The article aims to delve into these aspects and their implications for the broader healthcare market.
Bank of America sees positive April data for Tenet Healthcare, neutral for HCA Healthcare
Bank of America's "Traffic Signals" report, based on Placer.ai foot traffic data, indicated positive trends for Tenet Healthcare (THC) in April, with its second-quarter foot traffic year-over-year growth exceeding consensus estimates. HCA Healthcare (HCA) showed neutral results, with its implied Q2 volume growth matching consensus. Other hospital companies like Universal Health Services (UHS) and Acadia Healthcare (ACHC) saw foot traffic growth fall below expectations.
Amgen Stock Analysis: Repatha Surges 34% But Tax Litigation Clouds the Return Case. Here’s What to Expect
Amgen Inc. (AMGN) reported strong Q1 2026 earnings driven by a 34% surge in Repatha sales and 25% growth in its rare disease portfolio. However, the company faces two significant challenges: potential FDA withdrawal of its drug Tavneos and a looming $10.7 billion IRS tax litigation related to its Puerto Rico operations. Despite these overhangs, Amgen raised its full-year guidance, while analysts remain divided, with many holding their positions due to the unresolved legal issues, and the stock is currently deemed fairly valued.
Bank of America sees positive April data for Tenet Healthcare, neutral for HCA Healthcare
Bank of America's "Traffic Signals" report, analyzing April foot traffic data, indicates positive trends for Tenet Healthcare (THC) and neutral results for HCA Healthcare (HCA). While THC's implied Q2 volume growth is above consensus at 3.5% vs 1.3%, HCA's 2.1% growth matches expectations. The report also highlights decelerations for Universal Health Services (UHS) and Acadia Healthcare (ACHC) compared to their first-quarter performance.
HCA Healthcare, Inc. (HCA): Investor Outlook Highlights 21.30% Potential Upside
HCA Healthcare, Inc. (HCA) shows a promising 21.30% potential upside with a market cap of $93.84 billion, despite a recent slight dip in share price. Analysts project an average target price of $513.10 for the stock, currently trading near its 52-week low. The company exhibits robust financials, including strong revenue growth, solid EPS, and significant free cash flow, alongside a positive analyst sentiment and an oversold technical indicator suggesting potential for a rebound.
DLH Holdings Corp stock (US23330X1028): contracts and earnings keep government services specialist in focus
DLH Holdings Corp remains a key player in US government services, driven by recent federal contract wins and solid quarterly results. The company specializes in health, human services, and defense programs, aligning its growth with US federal spending priorities. Investors are focused on DLH's order backlog and margin trends to gauge its future performance and its role in structural themes like aging veteran populations and digital transformation of government services.
Why HCA Healthcare Stock Appears to be a Buy After the Post-Earnings Drop to $423
HCA Healthcare's stock dropped 8% after its Q1 2026 earnings report, despite beating revenue and adjusted EPS estimates, primarily due to a shortfall in respiratory-related admissions caused by a mild flu season and a January winter storm. Analysts view this as a temporary, not structural, issue, with most maintaining Buy ratings and a mean target price suggesting significant upside. TIKR's valuation model also indicates the stock is undervalued, projecting an 82% total return potential.
Qsemble Capital Management LP Takes Position in HCA Healthcare, Inc. $HCA
Qsemble Capital Management LP recently acquired a new stake in HCA Healthcare, purchasing 7,158 shares valued at approximately $3.34 million during the fourth quarter. Despite HCA reporting slightly lower-than-expected quarterly earnings of $7.15 per share, its revenue increased by 4.3% year-over-year to $19.11 billion, and the company declared a quarterly dividend of $0.78 per share. Analysts a "Moderate Buy" rating for HCA Healthcare, with an average price target of $517.82.
Northwestern Mutual Wealth Management Co. Acquires 649,058 Shares of HCA Healthcare, Inc. $HCA
Northwestern Mutual Wealth Management Co. significantly increased its stake in HCA Healthcare (NYSE:HCA) during the fourth quarter, acquiring 649,058 additional shares to bring its total holdings to 663,337 shares valued at $309.7 million. Despite HCA Healthcare's stock seeing a 2.3% decrease and missing analyst EPS expectations slightly, analysts maintain a generally positive outlook with a consensus "Moderate Buy" rating. The company also announced a quarterly dividend of $0.78 per share.
Arbejdsmarkedets Tillaegspension Takes $22.23 Million Position in HCA Healthcare, Inc. $HCA
Arbejdsmarkedets Tillaegspension initiated a new $22.23 million position in HCA Healthcare during the fourth quarter, purchasing 47,613 shares. Institutional investors collectively own 62.73% of the company, and despite a recent insider sale by EVP Michael R. McAlevy, analysts maintain a "Moderate Buy" rating with an average price target of $517.82. HCA Healthcare recently reported earnings, missing analyst estimates slightly, and declared a quarterly dividend of $0.78 per share.
ANTIPODES PARTNERS Ltd Sells 67,659 Shares of HCA Healthcare, Inc. $HCA
ANTIPODES PARTNERS Ltd reduced its stake in HCA Healthcare by 18.7% in the fourth quarter, selling 67,659 shares. Following this sale, the fund retains 294,520 shares, valued at approximately $137.5 million. HCA Healthcare recently reported mixed quarterly results, with EPS missing estimates but revenue slightly exceeding expectations, and declared a quarterly dividend of $0.78 per share.
HCA Healthcare (HCA) Funding Strategy Expands – Here’s How
HCA Healthcare, Inc. recently completed a $3 billion public offering of senior unsecured notes to diversify its long-term funding and enhance financial flexibility, with tranches maturing between 2031 and 2036. This move comes as the company integrates generative AI into clinical workflows. Despite a recent price target reduction by Bernstein due to risks like slowing state payments, HCA aims to offset challenges through strong operational execution and controlled margins.
HCA Healthcare Stock Rallies Amid Growth Optimism
HCA Healthcare's stock rose 1.21% recently, closing at $432.70, indicating investor optimism despite being 22.25% below its 52-week high. The company's strategy involves leveraging its scale in urban markets, focusing on outpatient services, and showing strong financial performance with 6.7% revenue growth and healthy operating margins. HCA also initiated a $10 billion share repurchase program, signaling confidence in future cash flow, though potential headwinds like policy changes under the Affordable Care Act remain a consideration.
HCA Healthcare Inc. stock outperforms competitors despite losses on the day
HCA Healthcare Inc. (HCA) shares dropped by 2.24% to $423.00 on Friday, despite the broader market also experiencing losses with the S&P 500 and Dow Jones Industrial Average falling. The company's stock closed 23.99% below its 52-week high of $556.52.
AustralianSuper Pty Ltd Purchases 95,181 Shares of HCA Healthcare, Inc. $HCA
AustralianSuper Pty Ltd significantly increased its stake in HCA Healthcare Inc. by 201.7% in Q4, acquiring 95,181 additional shares to reach a total of 142,372 shares valued at approximately $66.5 million. HCA Healthcare recently reported Q1 earnings of $7.15 per share, slightly below analyst expectations, with revenues up 4.3% year-over-year. The company maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $517.82, and has declared a quarterly dividend of $0.78 per share.
Ameritas Advisory Services LLC Has $1.62 Million Holdings in HCA Healthcare, Inc. $HCA
Ameritas Advisory Services LLC significantly increased its stake in HCA Healthcare, Inc. by 7,112.5% in the fourth quarter, bringing its total holdings to $1.62 million. Other institutional investors also boosted their positions, with institutions and hedge funds now owning 62.73% of HCA's stock. Despite missing earnings estimates slightly, HCA reported strong revenue and declared a quarterly dividend of $0.78 per share.
Is HCA Healthcare Stock A Trap Or A Missed Opportunity?
HCA Healthcare (HCA) stock is presented as a strong investment due to its growth, cash flow, margins, low debt, and modest valuation, despite potential headwinds from ACA policy changes. The article highlights HCA's dominant market share and strategic focus on outpatient services, backed by a significant share repurchase program. While there is a bullish sentiment, the bears contend the ACA changes might have a worse impact than guided, leading to an earnings miss.
FTI Consulting Survey: Majority of U.S. Hospital Leaders Predict Serious Financial Challenges in the Near Future
A new survey by FTI Consulting reveals that 92% of U.S. hospital leaders expect major financial challenges over the next decade due to affordability concerns, policy shifts, and care moving outside hospitals. The survey highlights interconnected pressures including physician recruitment constraints, data security concerns, and workforce shortages. Despite digital advancements, increased patient wait times persist, and while AI concerns have moderated, cybersecurity and data privacy are now top technological worries for hospitals.
HCA Healthcare stock (US42225T1079): Q1 earnings miss sparks 8% YTD drop
HCA Healthcare reported Q1 2026 earnings per share of $7.15, missing consensus estimates by $0.04. Following this, the company's stock has dropped 8.2% year-to-date to $428, despite analysts maintaining a "Moderate Buy" rating and seeing a 21% upside to a $518 price target. The article highlights HCA's large hospital network, aggressive share buybacks, and its position within the resilient U.S. healthcare sector.
First Majestic Silver (AG) falls 3.7% as investors digest strong Q1 results and take profits
First Majestic Silver (AG) experienced a 3.7% drop after reporting strong Q1 2026 financial results, which included a 95% year-over-year revenue increase and a raised quarterly dividend. This decline is attributed to post-earnings profit-taking and the inherent volatility of silver-linked equities. The company produced 3.5 million ounces of silver and 34,341 ounces of gold, and several analysts have recently issued price targets for AG.
VIRGINIA RETIREMENT SYSTEMS ET Al Has $23.83 Million Position in ResMed Inc. $RMD
VIRGINIA RETIREMENT SYSTEMS ET Al reduced its stake in ResMed Inc. (NYSE:RMD) by 27.6% in the fourth quarter, holding 98,940 shares valued at approximately $23.83 million. ResMed reported strong quarterly results with EPS of $2.86 and revenue of $1.43 billion, and declared a quarterly dividend of $0.60 per share. Analysts currently rate the stock as a "Moderate Buy" with an average target price of $286.18, despite recent insider stock sales.
HCA Healthcare Inc. stock outperforms competitors on strong trading day
Shares of HCA Healthcare Inc. (HCA) rose by 1.21% to $432.70 on Thursday, outperforming the broader market which also saw gains with the S&P 500 up 0.77% and the Dow Jones Industrial Average up 0.75%. The stock closed 22.25% below its 52-week high.
HCA Healthcare (BIT:1HCA) - Stock Analysis
HCA Healthcare (BIT:1HCA) is analyzed as trading below its estimated fair value with projected annual earnings growth of 4.04%. The company recently announced executive changes, quarterly dividends, and details regarding board refreshment, which was noted as insufficient by Simply Wall St's risk model. Recent analysis also highlighted HCA Healthcare's negative shareholder equity and a new minor risk related to share price stability.
SFL (NYSE: SFL) swings to Q1 2026 profit while managing heavy debt and newbuild spend
SFL Corporation Ltd. reported a significant turnaround in Q1 2026, achieving a net income of $26.1 million compared to a $31.9 million loss in the prior year, driven by reduced operating expenses and a gain from the sale of a Suezmax tanker. Despite facing heavy debt of approximately $2.52 billion and committing $848.1 million to new container vessel constructions, the company maintains strong liquidity and is actively managing its refinancing needs. SFL also declared a cash dividend of $0.20 per share, later increasing it to $0.22 per share, while noting that geopolitical conflicts in the Red Sea and Persian Gulf have not materially affected its operations to date.
EBR Systems Secures Purchasing Agreement With HCA Healthcare; Shares Up 10%
EBR Systems has secured a purchasing agreement with HCA Healthcare, which will make its WiSE CRT System available to HCA's network of hospitals and facilities. This agreement is expected to significantly expand access to the WiSE System for patients in the U.S. and has led to a 10% increase in EBR Systems' shares.
VIRGINIA RETIREMENT SYSTEMS ET Al Lowers Stock Holdings in HCA Healthcare, Inc. $HCA
Virginia Retirement Systems ET Al reduced its stake in HCA Healthcare by 2.9% in the fourth quarter of an unspecified year, selling 8,480 shares and ending with 288,820 shares valued at approximately $134.8 million. HCA Healthcare reported quarterly EPS of $7.15, slightly below analyst expectations, but revenue of $19.11 billion exceeded estimates and grew 4.3% year over year. The company declared a quarterly dividend of $0.78 per share payable on June 30, and analysts currently rate the stock as a "Moderate Buy" with a consensus price target of $517.82.
Summit Wealth Group LLC Co. Makes New $1.90 Million Investment in HCA Healthcare, Inc. $HCA
Summit Wealth Group LLC has made a new $1.90 million investment in HCA Healthcare, acquiring 4,065 shares. Institutional investors collectively own 62.73% of HCA, a for-profit operator of healthcare facilities. The company recently reported quarterly EPS of $7.15 and revenue of $19.11 billion, and declared a quarterly dividend of $0.78 per share.
